Colorectal Cancer Trials in santa monica, united states
Conditions / Colorectal Cancer / santa monica, united states
Clinical trials for Colorectal Cancer investigate a range of treatment strategies and patient populations.
32 total trials for this combination
Showing top 10 of 32 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02753127 | A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer | COMPLETED | PHASE3 |
| NCT03170960 | Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT04068896 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | COMPLETED | PHASE1/PHASE2 |
| NCT05919264 | FOG-001 in Locally Advanced or Metastatic Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT04913337 | Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT04682431 | A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors | TERMINATED | PHASE1 |
| NCT04566393 | Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies | AVAILABLE | — |
| NCT02568267 | Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04981119 | Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing | RECRUITING | — |
| NCT00012389 | Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | COMPLETED | PHASE3 |